Goodrich Katherine 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Jan 14, 2026
Insider Transaction Report
Form 4
Goodrich Katherine
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2025-12-15+2,233→ 2,233 total - Exercise/Conversion
Restricted Stock Units
[F2][F3]2025-12-15−2,233→ 4,467 total→ Common Stock (2,233 underlying)
Footnotes (3)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F2]Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F3]The RSUs will vest in three equal installments on December 15th of 2025, 2026 and 2027, subject to the Reporting Person's continuous service.
Signature
/s/ Scott Sieckert, Attorney-in-Fact|2026-01-14